(Glu1)-Fibrinopeptide B
Not For Human Use, Lab Use Only.
Cat.#: 300884
Special Price 177.10 USD
-
Product Name
(Glu1)-Fibrinopeptide B
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
EGVNDNEEGFFSAR
-
Sequence
H-Glu-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-OH
-
Length (aa)
14
-
Peptide Purity (HPLC)
97.4%
-
Molecular Formula
C66H95N19O26
-
Molecular Weight
1570.59
-
CAS No.
103213-49-6
-
Source
Synthetic
-
Form
Powder
-
Description
Human fibrinopeptide B (hFpB) is a 14-amino acid peptide cleaved from the amino-terminus of the fibrinogen Bβ-chain by the action of thrombin. It is a proteolytic product generated during fibrin formation and is also contained within the primary plasmin cleavage fragment of fibrinogen, Bβ 1-42. This peptide exhibits potent chemotactic activity for human neutrophils (PMN), with optimal activity observed at approximately 10-8 M. Its chemotactic potency for neutrophils is comparable to that of well-established chemoattractants such as C5a, leukotriene B4, and formyl-methionyl-leucyl-phenylalanine.
Studies indicate that hFpB stimulates directed migration of neutrophils and fibroblasts. The chemotactic response to hFpB is specific, as it is blocked by pre-incubation with anti-hFpB antiserum. Furthermore, evidence suggests hFpB acts through a receptor mechanism distinct from those used by C5a, LTB4, or fMLP. Like fMLP, hFpB induces a rapid, dose-dependent increase in cytoskeletal-associated actin in neutrophils. However, unlike fMLP, hFpB does not trigger neutrophil aggregation, lysosomal enzyme release, or superoxide anion production. This profile indicates hFpB can recruit specific cell types without concurrently activating certain pro-inflammatory secretory pathways.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- Senior RM, Skogen WF, Griffin GL, Wilner GD. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest. 1986 Mar;77(3):1014-9. doi: 10.1172/JCI112353. PMID: 3005361; PMCID: PMC423507.
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
-
Molar Concentration Calculator
-
Dilution Calculator
-
Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"